Cited by 250Muscle Physiology and DisordersNutrition and Health in AgingGrowth Hormone and Insulin-like Growth Factors

Effects of IGF-1 isoforms on muscle growth and sarcopenia

Open access
Ascenzi, Francesca, Barberi, Laura, Dobrowolny, Gabriella, Villa Nova Bacurau, Aline, Nicoletti, Carmine, Rizzuto, Emanuele, Rosenthal, Nadia, Scicchitano, Bianca Maria +1 more·2019·Aging Cell

Abstract

The decline in skeletal muscle mass and strength occurring in aging, referred as sarcopenia, is the result of many factors including an imbalance between protein synthesis and degradation, changes in metabolic/hormonal status, and in circulating levels of inflammatory mediators. Thus, factors that increase muscle mass and promote anabolic pathways might be of therapeutic benefit to counteract sarcopenia. Among these, the insulin-like growth factor-1 (IGF-1) has been implicated in many anabolic pathways in skeletal muscle. IGF-1 exists in different isoforms that might exert different role in skeletal muscle. Here we study the effects of two full propeptides IGF-1Ea and IGF-1Eb in skeletal muscle, with the aim to define whether and through which mechanisms their overexpression impacts muscle aging. We report that only IGF-1Ea expression promotes a pronounced hypertrophic phenotype in young mice, which is maintained in aged mice. Nevertheless, examination of aged transgenic mice revealed that the local expression of either IGF-1Ea or IGF-1Eb transgenes was protective against age-related loss of muscle mass and force. At molecular level, both isoforms activate the autophagy/lysosome system, normally altered during aging, and increase PGC1-α expression, modulating mitochondrial function, ROS detoxification, and the basal inflammatory state occurring at old age. Moreover, morphological integrity of neuromuscular junctions was maintained and preserved in both MLC/IGF-1Ea and MLC/IGF-1Eb mice during aging. These data suggest that IGF-1 is a promising therapeutic agent in staving off advancing muscle weakness.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/acel.12954

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Among IGF1 isoforms, IGF-1Ea is the most powerful in increasing muscle mass and force both in young and aged mice.

    “Among the different IGF1 isoforms, which differ in the N‐terminal signal peptide (Class 1 or 2) and the C‐terminal extension peptide (E‐peptide Ea or Eb), IGF-1Ea is the most powerful in increasing muscle mass and force both in young and aged mice7.”
  • IGF-1 controls skeletal muscle anabolism and catabolism, exerting anabolic effects by regulating mitochondrial function, ROS detoxification, and the basal inflammatory state in aging individuals.

    “IGF-1, a key factor controlling skeletal muscle anabolism and catabolism, exerts its anabolic effects on skeletal muscle by regulating mitochondrial function, ROS detoxification, and the basal inflammatory state in aging individuals [106].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Ascenzi, F., Barberi, L., Dobrowolny, G., Villa Nova Bacurau, A., Nicoletti, C., Rizzuto, E., Rosenthal, N., Scicchitano, B. M., & Musarò, A.
Affiliations
  • Istituto Pasteur (IT)
  • School of Physical Education and Sport University of São Paulo São Paulo Brazil
  • Sapienza University of Rome (IT)
  • Jackson Laboratory (US)
  • Università Cattolica del Sacro Cuore (IT)
Corresponding author
Musarò, Antonio
Venue
Aging Cell
Publisher
Wiley
Published
2019-04-05
Volume
18
Issue
3
Pages
e12954-e12954
ISSN
  • 1474-9718 (ISSN-L)
  • 1474-9726
OpenAlex
W2926702890
Cited by
250
References
39
Citations by year
2026: 21 · 2025: 33 · 2024: 36 · 2023: 44 · 2022: 33 · 2021: 46 · 2020: 30 · 2019: 7
FWCI
9.59
Type
journal article
Language
en
Open access
Locations
  • Aging Cell (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • IRIS Research product catalog (Sapienza University of Rome) (submittedVersion, cc-by)
  • The Mouseion at the JAXlibrary (Jackson Laboratory) (submittedVersion, cc-by)
  • The Mouseion at the JAXlibrary (Jackson Laboratory) (submittedVersion)
  • PubliCatt (Università Cattolica del Sacro Cuore) (submittedVersion, cc-by)
  • Spiral (Imperial College London) (submittedVersion, cc-by)
Funders
Agenzia Spaziale Italiana
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
  • Health Sciences › Medicine › Physiology › Nutrition and Health in Aging
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
Keywords
insulin-like growth factor I, sarcopenia, muscle aging, skeletal muscle hypertrophy, autophagy-lysosome system, PGC-1α, mitochondrial function, reactive oxygen species, inflammation, neuromuscular junction, muscle mass and strength, transgenic mice
MeSH terms
Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha, Aging, Animals, Inflammation, Insulin-Like Growth Factor I, Mice, Transgenic, Mitochondria, Neuromuscular Junction, Signal Transduction, Up-Regulation, Reactive Oxygen Species, Muscle, Skeletal, Protein Isoforms, Mice, Sarcopenia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review